73 related articles for article (PubMed ID: 6574820)
1. Phase II trial of 4'-epi-doxorubicin in patients with non-small cell lung cancer.
Kalman LA; Kris MG; Gralla RJ; Kelsen DP; Casper ES; Heelan RT; Wittes RE
Cancer Treat Rep; 1983 Jun; 67(6):591-2. PubMed ID: 6574820
[No Abstract] [Full Text] [Related]
2. Phase II trial of 4'-epi-doxorubicin in advanced colorectal carcinoma: a Northern California Oncology Group study.
Meyers FJ; Lewis B; Mitchell E; William L; Hannigan JF; Gribble M; Torti FM
Cancer Treat Rep; 1985 Jan; 69(1):143-4. PubMed ID: 3855385
[No Abstract] [Full Text] [Related]
3. [A phase I trial of 4'-epiadriamycin].
Ogawa M; Ikeda K; Inagaki J; Horikoshi N; Inoue K; Nakada K; Usui N; Okada Y; Adachi K; Tada A
Gan To Kagaku Ryoho; 1984 Apr; 11(4):926-9. PubMed ID: 6586111
[TBL] [Abstract][Full Text] [Related]
4. Phase II evaluation of 4'-epi-doxorubicin in patients with advanced colorectal carcinoma.
Michaelson R; Kemeny N; Young C
Cancer Treat Rep; 1982 Sep; 66(9):1757-8. PubMed ID: 6956441
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of esorubicin in patients with advanced non-small cell lung cancer.
Kris MG; Gralla RJ; Burke MT; Fiore JJ; Kelsen DP; Marks LD; Heelan RT
Cancer Treat Rep; 1987; 71(7-8):783-4. PubMed ID: 3038319
[No Abstract] [Full Text] [Related]
6. Phase II trial of 4'-deoxydoxorubicin in advanced non-small cell lung cancer.
Conley BA; Hornedo J; Abrams J; Eisenberger M; Hiponia D; Aisner J; Van Echo DA
Cancer Treat Rep; 1987 Sep; 71(9):861-2. PubMed ID: 3040246
[No Abstract] [Full Text] [Related]
7. Phase II study of the combination of dianhydrogalactitol, doxorubicin, and cisplatin (DAP) in patients with advanced squamous cell lung cancer.
Eagan RT; Frytak S; Nichols WC; Ingle JN; Creagan ET; Kvols LK
Cancer Treat Rep; 1981; 65(5-6):517-9. PubMed ID: 7195306
[No Abstract] [Full Text] [Related]
8. Phase II study of 4'-epi-doxorubicin in advanced breast cancer.
Campora E; Nobile MT; Sertoli MR; Rosso R
Cancer Treat Rep; 1984 Oct; 68(10):1285-6. PubMed ID: 6597003
[No Abstract] [Full Text] [Related]
9. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
10. Phase I-II study of the continuous infusion of doxorubicin in the treatment of non-small cell lung cancer.
Green MD; Speyer JS; Bottino JC; Blum RH; Wernz JC; Muggia FM
Cancer Treat Rep; 1984 Apr; 68(4):681-2. PubMed ID: 6713422
[No Abstract] [Full Text] [Related]
11. Phase II trial of 4'-deoxydoxorubicin in advanced non-small cell lung cancer.
Kaplan S; Sessa C; Joss R; Obrecht JP; Siegenthaler P; Cavalli F
Cancer Treat Rep; 1985 Nov; 69(11):1337-8. PubMed ID: 4092200
[No Abstract] [Full Text] [Related]
12. Phase II trial of 4'epi-adriamycin for advanced hypernephroma.
Benedetto P; Ahmed T; Needles B; Watson RC; Yagoda A
Am J Clin Oncol; 1983 Oct; 6(5):553-4. PubMed ID: 6577784
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of weekly low-dose 4'-epi-doxorubicin in advanced postmenopausal breast cancer.
Jones WG; Mattsson W
Cancer Treat Rep; 1984 Apr; 68(4):675-7. PubMed ID: 6585271
[TBL] [Abstract][Full Text] [Related]
14. [A phase I study of 4'-epi-adriamycin, a new anthracycline anticancer agent].
Kimura K; Wakui A; Saito T; Tominaga T; Niitani H; Fujimoto T; Masaoka T; Toki H; Tamura K
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2414-9. PubMed ID: 6594078
[TBL] [Abstract][Full Text] [Related]
15. Epirubicin in non-oat cell lung cancer--response rates and the importance of immunopathology: a Northern California Oncology Group Study.
Meyers FJ; Cardiff RD; Quadro R; Gribble M; Kohler M; Medrano V; Mitchell EP; Shiffman R; William L
Cancer Treat Rep; 1986 Jun; 70(6):805-6. PubMed ID: 2425963
[No Abstract] [Full Text] [Related]
16. Phase II study of 4'-epi-doxorubicin in metastatic renal cancer.
Fosså SD; Wik B; Bae E; Lien HH
Cancer Treat Rep; 1982 May; 66(5):1219-21. PubMed ID: 6952962
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of 4'-epi-doxorubicin in patients with advanced malignant melanoma.
Berman E; Casper ES; Howard J; Wittes RE
Cancer Treat Rep; 1984 Apr; 68(4):679-80. PubMed ID: 6585272
[TBL] [Abstract][Full Text] [Related]
18. Treatment of advanced non-small cell lung cancer with bisantrene.
Fuks JZ; Van Echo DA; Garbino C; Kasdorf H; Aisner J
Cancer Treat Rep; 1983 Jun; 67(6):597-8. PubMed ID: 6305499
[No Abstract] [Full Text] [Related]
19. 4'-Epi-Doxorubicin -- a clinical phase-II trial in solid tumors.
Schütte J; Niederle N; Grunenberg B; Krischke W; Seeber S; Schmidt CG
J Cancer Res Clin Oncol; 1984; 107(1):38-41. PubMed ID: 6583205
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of 4-demethoxydaunorubicin in patients with non-small cell lung cancer.
Joss RA; Obrecht JP; Alberto P; Siegenthaler P; VanHelvoirt A; Cavalli F
Cancer Treat Rep; 1984 Mar; 68(3):563-4. PubMed ID: 6322990
[No Abstract] [Full Text] [Related]
[Next] [New Search]
